Dr. Singh is the managing director at Artiman Ventures, a venture capital firm focused on early-stage technology and life science investments. He is also chairman of the board of oncology focused companies CORE Diagnostics and Sofie Biosciences, serves on the boards of Max Healthcare and Cadila Pharmaceuticals, is a senior advisor to the Tata Trusts Cancer Care program, and is an adjunct professor at the School of Medicine at Stanford. Dr. Singh previously served as the CEO of Siemens Oncology and as CEO of BioImagene, a cancer diagnostics startup that was acquired by Roche. He has published two books and holds five patents.